Dr Lindsay Bearne, Chief Investigator of the MOSAIC Trial, delivered last month a presentation about the MOSAIC Trial at King’s College London’s Rehabilitation Research Showcase. The showcase attracted delegates from a range of healthcare disciplines and the audience included students, healthcare practitioners and academics.
The MOSAIC intervention was systematically developed over four years by Dr Melissa Galea Holmes, Professor John Weinman and Dr Lindsay Bearne. The main aim of the trial is to assess whether the MOSAIC intervention improves walking ability at three-months compared to usual care for patients with intermittent claudication caused by Peripheral Arterial Disease. In Lindsay’s talk, she shared details on how MOSAIC was developed based on Medical Research Council guidelines and highlighted the key features of the MOSAIC intervention. Delegates were interested to hear more about the main outcome measure being used for the trial, and whether participants’ body mass index was being recorded.
The talk gave delegates a sense of how our preliminary research informed the development of the MOSAIC intervention and trial. The talk coincided with the publication of our feasibility study ‘A randomised controlled feasibility trial of a home-based walking behaviour-change intervention for people with intermittent claudication’ in the Journal of Vascular Nursing.
Lindsay comments that “It was an honour to be invited to present the development of the MOAIC intervention and design of MOSAIC trial to this interested audience”.
The day showcased leading rehabilitation research by Researchers at King’s College London evoking stimulating discussions and thoughts about ongoing research, implementation and collaboration.
The full MOSAIC Trial feasibility study is available at: https://kclpure.kcl.ac.uk/portal/en/persons/lindsay-bearne(ea7d99c0-4683-4be5-b706-ac7eaa1242cc)/publications.html
Link to departmental twitter account: https://twitter.com/Physio_KCL